Revoche e sospensioni, ritiri di lotti, farmaci carenti, note di sicurezza, rimborsabilità e nuovi medicinali — ogni giorno, automaticamente. Ultimo aggiornamento: 17/11/2026 08:15.
n. EU/1/26/2024 · Rhapsido is indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients with inadequa… · Novartis Europharm Limited · remibrutinib · ATC L04AA60
n. EU/1/25/2008 · Early breast cancer
Poherdy is indicated for use in combination with trastuzumab and chemotherapy in:
• the … · N.V. Organon · pertuzumab · ATC L01FD02
n. EU/1/26/2021 · Palsonify is indicated for the medical treatment of adult patients with acromegaly. · Crinetics Pharmaceuticals Europe GmbH · paltusotine · ATC H01CB06
n. EU/1/26/2023 · Rheumatoid arthritis
Fubelv in combination with methotrexate is indicated for the treatment of moderate to … · Biocon Biologics Ireland Limited · etanercept · ATC L04AB01
Problemi produttivi: distribuzione contingentata · equivalente: Sì · 50 mg/ml SOLUZIONE INIETTABILE O PER INFUSIONE- 1 FLACONCINO IN VETRO DA 10 ML · AIC 050380043 · SANDOZ S.P.A. · CARBOSSIMALTOSIO FERRICO · ATC B03AC
n. EU/1/26/2028 · mCOMBRIAX is indicated for active immunisation for the prevention of influenza disease and COVID-19 caused by … · Moderna Biotech Spain S.L. · Influenza and COVID 19, mRNA vaccine · ATC Pending
n. EU/1/26/2025 · Ojemda is indicated as monotherapy for the treatment of patients 6 months of age and older with paediatric low… · Ipsen Pharma · tovorafenib · ATC L01EC04
Problemi produttivi · equivalente: Sì · 40MG/5MG COMPRESSE RIVESTITE CON FILM - 28 COMPRESSE IN BLISTER OPA/AL/PVC/AL · AIC 045162082 · ZENTIVA ITALIA S.R.L. · OLMESARTAN MEDOXOMIL/AMLODIPINA · ATC C09DB02